Johnson & Johnson (Australia)

Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth

Roger G. Fahmy, Crispin R. Dass, Lunquan Sun et al. · Nature Medicine · 2003 · 366 citations

Tumor Biology, Developmental Biology, Angiogenesis +12

RNAi-mediated replacement of morphine with the nonnarcotic alkaloid reticuline in opium poppy

Robert S. Allen, Anthony G. Millgate, Julie A. Chitty et al. · Nature Biotechnology · 2004 · 291 citations

Molecular Pharmacology, Opium Poppy, Biochemistry +6

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

Ronald T. Mitsuyasu, Thomas C. Merigan, Andrew Carr et al. · Nature Medicine · 2009 · 263 citations · Full text

Gene Therapy Trial, Medicine, Human Retrovirus +11

Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer

Greg M. Arndt, Lesley Dossey, Lara M. Cullen et al. · BMC Cancer · 2009 · 261 citations · Full text

New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury

Fernando S. Santiago, Harry C. Lowe, Mary M. Kavurma et al. · Nature Medicine · 1999 · 211 citations

Systems Biology, Molecular Physiology, Angiogenesis +9